VET-STEM ANNOUNCES PARTICIPATION IN THE 2011 STEM CELL MEETING ON THE MESA'S INVESTOR AND PARTNERING FORUM
VET-STEM ANNOUNCES PARTICIPATION IN THE 2011 STEM CELL MEETING ON THE MESA’S INVESTOR AND PARTNERING FORUM
Poway, CA November 18, 2011 – Vet-Stem Inc., today announced that Dr. Robert Harman, founder and CEO of Vet-Stem Regenerative Veterinary Medicine will be presenting at the 2011 Stem Cell Meeting on the Mesa’s Investor and Partnering Forum.
The company presentation will be webcasted by the Alliance for Regenerative Medicine and made available on Vet-Stem’s website shortly after the event. (The webcast will also be available on ARM’s website)
The following are specific details regarding Vet-Stem’s presentation at the conference:
2011 Stem Cell Meeting on the Mesa’s Investor and Partnering Forum
Date: November 30, 2011
Location: Sanford Consortium for Regenerative Medicine Building
10010 North Torrey Pines Road, La Jolla, California
About the Stem Cell Meeting on the Mesa’s Investor and Partnering Forum:
The Investor and Partnering Forum is being organized by the Sanford Consortium, CIRM and The Alliance for Regenerative Medicine (ARM) to facilitate translational research, promote engagement between the scientific and business communities and provide opportunities for business, academic research and investor participants to connect in one-on-one strategic partnering meetings. To learn more or to register for the 2011 Stem Cell Meeting on the Mesa Symposium and Investor & Partnering Forum, please visit www.stemcellmeetingonthemesa.com
About Vet-Stem, Inc.:
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. This privately held company delivers stem cell and related services and products to veterinarians to treat diseases in dogs, cats and horses. These technologies utilize the natural healing properties inherent in all animals to reduce pain and improve the quality of life of our animal companions.
In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. Since that time there has been rapid adoption of this technology for treatment of tendon, ligament, and joint injuries by the veterinary community. Published studies have confirmed that these stem cells can dramatically improve the healing of injuries and diseases that have had very few treatment options in the past.
Chief Operating Officer
Ph: 858-748-2004 ext 102